IL136634A0 - Recombinant noda virus compositions and methods - Google Patents
Recombinant noda virus compositions and methodsInfo
- Publication number
- IL136634A0 IL136634A0 IL13663498A IL13663498A IL136634A0 IL 136634 A0 IL136634 A0 IL 136634A0 IL 13663498 A IL13663498 A IL 13663498A IL 13663498 A IL13663498 A IL 13663498A IL 136634 A0 IL136634 A0 IL 136634A0
- Authority
- IL
- Israel
- Prior art keywords
- recombinant
- methods
- nodavirus
- particles
- cell
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000001476 gene delivery Methods 0.000 abstract 1
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/30011—Nodaviridae
- C12N2770/30022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/802—Virus-based particle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/882—Assembling of separate components, e.g. by attaching
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/92—Detection of biochemical
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/986,659 US6171591B1 (en) | 1997-12-08 | 1997-12-08 | Recombinant nodavirus compositions and methods |
| PCT/US1998/025922 WO1999029723A1 (en) | 1997-12-08 | 1998-12-07 | Recombinant nodavirus compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136634A0 true IL136634A0 (en) | 2001-06-14 |
Family
ID=25532635
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13663498A IL136634A0 (en) | 1997-12-08 | 1998-12-07 | Recombinant noda virus compositions and methods |
| IL136634A IL136634A (en) | 1997-12-08 | 2000-06-07 | A chimeric protein comprising a flock house virus capsid protein free from deletions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL136634A IL136634A (en) | 1997-12-08 | 2000-06-07 | A chimeric protein comprising a flock house virus capsid protein free from deletions |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6171591B1 (xx) |
| EP (1) | EP1037917B1 (xx) |
| JP (1) | JP4503172B2 (xx) |
| AT (1) | ATE366743T1 (xx) |
| AU (1) | AU755201B2 (xx) |
| BR (1) | BR9813416A (xx) |
| CA (1) | CA2313704C (xx) |
| CY (1) | CY1106842T1 (xx) |
| DE (1) | DE69838073T2 (xx) |
| DK (1) | DK1037917T3 (xx) |
| ES (1) | ES2288769T3 (xx) |
| IL (2) | IL136634A0 (xx) |
| PT (1) | PT1037917E (xx) |
| WO (1) | WO1999029723A1 (xx) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU770802B2 (en) * | 1998-10-21 | 2004-03-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Virus-like particles for the induction of autoantibodies |
| EP1637166A3 (en) * | 1998-10-21 | 2006-04-12 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Virus-like particles for the induction of autoantibodies |
| US7476517B2 (en) | 1999-06-30 | 2009-01-13 | Evotec Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| US20040014033A1 (en) | 1999-06-30 | 2004-01-22 | Evotec Biosystems Ag, A Corporation Of Germany | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
| JP2003504014A (ja) * | 1999-06-30 | 2003-02-04 | エボテック オーアーイー アクチェンゲゼルシャフト | ウイルス状粒子、それらの調製及び好ましくは薬学的スクリーニング及び機能的ゲノムにおけるそれらの使用 |
| NZ530723A (en) | 2001-07-02 | 2006-02-24 | Bioincept Llc | New assays for PFI using the anti-CD2 antibodies T11 and preimplantation factor peptides |
| US8222211B2 (en) * | 2001-07-02 | 2012-07-17 | Bioincept, Llc | Methods of administering PIF agonist peptides and uses thereof |
| DE60234375D1 (de) * | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
| EP1318195A1 (en) * | 2001-12-10 | 2003-06-11 | CatchMabs B.V. | A structure for presenting desired peptide sequences |
| US9045727B2 (en) * | 2002-05-17 | 2015-06-02 | Emory University | Virus-like particles, methods of preparation, and immunogenic compositions |
| US20060088909A1 (en) * | 2002-05-17 | 2006-04-27 | Compans Richard W | Virus-like particles, methods of preparation, and immunogenic compositions |
| US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
| EP1605972A2 (en) | 2003-03-26 | 2005-12-21 | Cytos Biotechnology AG | Hiv-peptide-carrier-conjugates |
| US7723290B2 (en) * | 2004-10-22 | 2010-05-25 | Bioincept, Llc | Compositions and methods for modulating the immune system |
| JP2005272340A (ja) * | 2004-03-24 | 2005-10-06 | Japan Science & Technology Agency | ノダウイルスの感染予防法および治療法 |
| JP2009501001A (ja) | 2005-06-01 | 2009-01-15 | ダウ グローバル テクノロジーズ インコーポレイティド | 多価ウイルス様粒子の製造 |
| ES2310062B1 (es) | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
| CA2636139A1 (en) | 2005-12-14 | 2007-06-21 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| EP1835031A1 (en) | 2006-03-14 | 2007-09-19 | Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe | Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans |
| ES2427994T3 (es) | 2006-06-12 | 2013-11-05 | Cytos Biotechnology Ag | Procesos para empaquetar oligonucleótidos en partículas de tipo viral de bacteriófagos de ARN |
| JP5389662B2 (ja) | 2006-12-12 | 2014-01-15 | サイトス バイオテクノロジー アーゲー | 高濃度のグアニン・モノマーを含有するオリゴヌクレオチド |
| US7998487B2 (en) * | 2007-02-16 | 2011-08-16 | The Salk Institute For Biological Studies | Antitoxin and vaccine platform based on nodavirus VLPs |
| EP2139993A2 (en) * | 2007-04-27 | 2010-01-06 | Dow Global Technologies Inc. | Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| CA2703066A1 (en) * | 2007-10-22 | 2009-04-30 | University Of Rochester | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| WO2012119072A2 (en) | 2011-03-02 | 2012-09-07 | Bioincept, Llc | Compositions and methods for treatment of intracellular damage |
| PT2790737T (pt) | 2011-12-12 | 2019-02-28 | Childrens Hospital Philadelphia | Sistema de produção de vetores lentivirais a grande escala comercial e vetores produzidos pelo mesmo |
| JP6475336B2 (ja) * | 2014-08-21 | 2019-02-27 | チュン−アン ユニヴァーシティ インダストリー−アカデミー コーポレーション ファウンデーションＣｈｕｎｇ−Ａｎｇ Ｕｎｉｖｅｒｓｉｔｙ Ｉｎｄｕｓｔｒｙ−Ａｃａｄｅｍｙ Ｃｏｏｐｅｒａｔｉｏｎ Ｆｏｕｎｄａｔｉｏｎ | ｒＤＮＡ ＮＴＳ基盤の遺伝子多重挿入カセットセット、及びそれを用いたＧＲＡＳ等級の組換え酵母菌株 |
| EP3341739A4 (en) | 2015-08-28 | 2019-07-10 | BioIncept LLC | MUTATED PEPTIDES AND METHOD FOR TREATING SUBJECTS THEREWITH |
| CA2996874A1 (en) | 2015-08-28 | 2017-03-09 | Bioincept, Llc | Compositions and methods for the treatment of neurodamage |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5149650A (en) | 1986-01-14 | 1992-09-22 | University Of North Carolina At Chapel Hill | Vaccines for human respiratory virus |
| US4873192A (en) * | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
| EP0698666B1 (en) * | 1994-06-21 | 2006-04-26 | Sumitomo Electric Industries, Limited | Modified epimorphin |
| AT402898B (de) * | 1994-08-08 | 1997-09-25 | Int Centre Genetic Eng & Bio | Molekulares präsentiersystem |
| US5869287A (en) * | 1996-07-12 | 1999-02-09 | Wisconsin Alumni Research Foundation | Method of producing particles containing nucleic acid sequences in yeast |
-
1997
- 1997-12-08 US US08/986,659 patent/US6171591B1/en not_active Expired - Lifetime
-
1998
- 1998-12-07 IL IL13663498A patent/IL136634A0/xx active IP Right Grant
- 1998-12-07 EP EP98961962A patent/EP1037917B1/en not_active Expired - Lifetime
- 1998-12-07 JP JP2000524314A patent/JP4503172B2/ja not_active Expired - Fee Related
- 1998-12-07 WO PCT/US1998/025922 patent/WO1999029723A1/en active IP Right Grant
- 1998-12-07 PT PT98961962T patent/PT1037917E/pt unknown
- 1998-12-07 AT AT98961962T patent/ATE366743T1/de active
- 1998-12-07 AU AU17146/99A patent/AU755201B2/en not_active Ceased
- 1998-12-07 ES ES98961962T patent/ES2288769T3/es not_active Expired - Lifetime
- 1998-12-07 BR BR9813416-7A patent/BR9813416A/pt not_active Application Discontinuation
- 1998-12-07 DE DE69838073T patent/DE69838073T2/de not_active Expired - Lifetime
- 1998-12-07 DK DK98961962T patent/DK1037917T3/da active
- 1998-12-07 CA CA002313704A patent/CA2313704C/en not_active Expired - Fee Related
-
2000
- 2000-06-07 IL IL136634A patent/IL136634A/en not_active IP Right Cessation
-
2007
- 2007-09-04 CY CY20071101142T patent/CY1106842T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999029723A1 (en) | 1999-06-17 |
| EP1037917A4 (en) | 2003-02-26 |
| CA2313704A1 (en) | 1999-06-17 |
| CY1106842T1 (el) | 2012-05-23 |
| PT1037917E (pt) | 2007-09-19 |
| IL136634A (en) | 2007-09-20 |
| ATE366743T1 (de) | 2007-08-15 |
| AU1714699A (en) | 1999-06-28 |
| BR9813416A (pt) | 2001-10-16 |
| EP1037917B1 (en) | 2007-07-11 |
| DE69838073T2 (de) | 2008-03-20 |
| EP1037917A1 (en) | 2000-09-27 |
| JP2001525422A (ja) | 2001-12-11 |
| DE69838073D1 (de) | 2007-08-23 |
| JP4503172B2 (ja) | 2010-07-14 |
| ES2288769T3 (es) | 2008-01-16 |
| US6171591B1 (en) | 2001-01-09 |
| DK1037917T3 (da) | 2007-10-08 |
| CA2313704C (en) | 2009-04-07 |
| AU755201B2 (en) | 2002-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL136634A0 (en) | Recombinant noda virus compositions and methods | |
| ATE327259T1 (de) | Immunantwort gegen hpv antigene hervorgerufen von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einem expressionsvektor fähig zur expression dieser proteine | |
| AU2774389A (en) | Recombinant vaccinia virus mva | |
| NZ506553A (en) | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue | |
| EP2298793A3 (en) | Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits | |
| DE60041243D1 (de) | Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins | |
| MX2022013819A (es) | Capsides de virus adeno-asociado 5 modificado y usos del mismo. | |
| DE3682893D1 (de) | Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen. | |
| EP1253201A3 (en) | Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor | |
| NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
| Ishikawa et al. | Analysis of the binding of a host cell surface glycoprotein to the preS protein of duck hepatitis B virus | |
| MY110899A (en) | Dengue virus | |
| CY1107431T1 (el) | Σωματιδια για γoνιδιακη θεραπεια | |
| ES2194012T3 (es) | Epitopo p1a1 y p1a2 de la gpiii a de plaquetas, su preparacion y uso. | |
| ATE124420T1 (de) | Impfstoffe und testsätze für haemophilus influenzae. | |
| AP2368A (en) | Novel expression vectors and uses thereof. | |
| WO1992011370A3 (de) | Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung | |
| NZ242641A (en) | Herpesvirus particles lacking a capsid and viral dna and viral preparations containing them | |
| WO2001079473A3 (en) | 21953, a human prolyl oligopeptidase family member and uses thereof | |
| CU22642A1 (es) | Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso | |
| WO2002008395A3 (en) | Putative human methyltransferase family member and uses thereof | |
| WO2024124019A3 (en) | Aav vectors targeting hematopoietic stem cells | |
| WO2002088357A3 (en) | 84242, 8035, 55304, 52999, and 21999, novel human proteins and methods of use thereof | |
| AU2001285204A1 (en) | Atcr-1, a human acyltransferase and uses thereof | |
| WO2002051992A3 (en) | 21163, a novel human prolyl oligopeptidase and uses therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |